LUMOS PHARMA INC's ticker is LUMO and the CUSIP is 55028X109. A total of 37 filers reported holding LUMOS PHARMA INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2023 | $84 | -25.7% | 26,549 | -21.9% | 0.06% | -29.3% |
| Q1 2023 | $113 | -8.1% | 34,015 | 0.0% | 0.08% | -10.9% |
| Q4 2022 | $123 | -100.0% | 34,015 | 0.0% | 0.09% | -59.6% |
| Q3 2022 | $301,000 | +17.6% | 34,015 | 0.0% | 0.23% | +23.2% |
| Q2 2022 | $256,000 | -20.2% | 34,015 | 0.0% | 0.18% | -11.1% |
| Q1 2022 | $321,000 | +36.0% | 34,015 | 0.0% | 0.21% | +46.5% |
| Q4 2021 | $236,000 | -26.5% | 34,015 | 0.0% | 0.14% | -24.1% |
| Q3 2021 | $321,000 | – | 34,015 | – | 0.19% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Lion Point Capital, LP | 407,192 | $5,627,000 | 1.23% |
| Opaleye Management Inc. | 240,892 | $3,329,000 | 0.65% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 936,291 | $12,940,000 | 0.32% |
| NEA Management Company, LLC | 526,663 | $7,278,000 | 0.31% |
| Investors Financial Group, LLC | 21,766 | $301,000 | 0.22% |
| Wealth Advisors of Iowa, LLC | 11,760 | $163,000 | 0.11% |
| Blackstone Inc. | 468,145 | $6,470,000 | 0.02% |
| Jefferies Group LLC | 120,651 | $1,667,000 | 0.02% |
| Texas Yale Capital Corp. | 16,000 | $221,000 | 0.02% |
| Prospera Financial Services Inc | 1,088 | $15,000 | 0.01% |